Carl Koschmann, MD

Carl Koschmann, MD

University of Michigan

H-index: 25

North America-United States

About Carl Koschmann, MD

Carl Koschmann, MD, With an exceptional h-index of 25 and a recent h-index of 24 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Pediatric Neuro-Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Clinical and Biological Landscape of Constitutional Mismatch Repair Deficiency: An IRRDC Study

An unusual association of deletion of SMARCB1 in a patient with intracranial yolk sac tumor: A case-report

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

A road map for the treatment of pediatric diffuse midline glioma

Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

Abstract B045: Adaptive purine metabolism drives radiation therapy resistance in H3K27M-diffuse midline glioma

Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence

Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201

Carl Koschmann, MD Information

University

Position

___

Citations(all)

2321

Citations(since 2020)

1993

Cited By

889

hIndex(all)

25

hIndex(since 2020)

24

i10Index(all)

52

i10Index(since 2020)

50

Email

University Profile Page

University of Michigan

Google Scholar

View Google Scholar Profile

Carl Koschmann, MD Skills & Research Interests

Pediatric Neuro-Oncology

Top articles of Carl Koschmann, MD

Title

Journal

Author(s)

Publication Date

The Clinical and Biological Landscape of Constitutional Mismatch Repair Deficiency: An IRRDC Study

Ayse Bahar Ercan

Melyssa Aronson

Nicholas R Fernandez

Yuan Chang

Adrian Levine

...

2024/1/24

An unusual association of deletion of SMARCB1 in a patient with intracranial yolk sac tumor: A case-report

Pediatric Hematology Oncology Journal

A Gupte

E Al-Antary

K Regling

WJ Kupsky

D Altinok

...

2024/6/1

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

The Journal of Clinical Investigation

Ryan J Duchatel

Evangeline R Jackson

Sarah G Parackal

Dylan Kiltschewskij

Izac J Findlay

...

2024/3/15

A road map for the treatment of pediatric diffuse midline glioma

Cancer cell

Carl Koschmann

Wajd N Al-Holou

Marta M Alonso

Jamie Anastas

Pratiti Bandopadhayay

...

2024/1/8

Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

Cancer & Metabolism

Erik R Peterson

Peter Sajjakulnukit

Andrew J Scott

Caleb Heaslip

Anthony Andren

...

2024/4/9

Abstract B045: Adaptive purine metabolism drives radiation therapy resistance in H3K27M-diffuse midline glioma

Cancer Research

Erik R Peterson

Peter Sajjakulnukit

Andrew Scott

Caleb Heaslip

Anthony Andren

...

2024/3/4

Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence

Molecular cancer therapeutics

Monika Sharma

Ivana Barravecchia

Robert Teis

Jeanette Cruz

Rachel Mumby

...

2024/1/3

Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201

Neuro-oncology

Dazhuan Eric Xin

Yunfei Liao

Rohit Rao

Sean Ogurek

Soma Sengupta

...

2024/4/1

Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology

JCO Precision Oncology

Michelle F Jacobs

Joshua W Goldman

Sarah Austin

Erika S Koeppe

Andrea M Murad

...

2024/3

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma

Yazmin Odia

Carl Koschmann

Nicholas A Vitanza

Peter de Blank

Dolly Aguilera

...

2024/2/24

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

Neuro-oncology

Daniel de la Nava

Iker Ausejo-Mauleon

Virginia Laspidea

Marisol Gonzalez-Huarriz

Andrea Lacalle

...

2024/3/30

Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium

Cancer Discovery

Anirban Das

Nicholas R Fernandez

Adrian Levine

Vanessa Bianchi

Lucie K Stengs

...

2024/2/8

Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

The Lancet Oncology

Ayse Bahar Ercan

Melyssa Aronson

Nicholas R Fernandez

Yuan Chang

Adrian Levine

...

2024/3/26

DIPG-26. CLINICAL AND GENOMIC ANALYSIS OF H3K27M-DMG LONG-TERM SURVIVORS REVEALS ENRICHMENT IN MAPK PATHWAY ALTERATIONS

Holly Roberts

Alberto Picca

Marc Sanson

Ulrich Schüller

Thiébaud Picart

...

2023/6/1

BIOM-58. ZERO-WASTE MOLECULAR DIAGNOSTICS FROM BIOPSY NEEDLE WASHES

Neuro-Oncology

Jack Wadden

Vishal John

Michael Niculcea

Seongbae Kong

Rayan Aittaleb

...

2023/11/1

Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma

Leslie A Parsels

Daniel R Wahl

Carl Koschmann

Meredith A Morgan

Qiang Zhang

2023/3/1

Abstract C150: Targeted inhibition of homologous recombination and nonhomologous end joining in diffuse intrinsic pontine gliomas to prevent tumor recurrence

Molecular Cancer Therapeutics

Ivana Barravecchia

Monika Sharma

Robert Teis

Jeanette Cruz

Rachel Mumby

...

2023/12/1

The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science

Neoplasia

Jena V Lilly

Jo Lynne Rokita

Jennifer L Mason

Tatiana Patton

Stephanie Stefankiewiz

...

2023/1/1

OpenPBTA: The Open Pediatric Brain Tumor Atlas

Cell genomics

Joshua A Shapiro

Krutika S Gaonkar

Stephanie J Spielman

Candace L Savonen

Chante J Bethell

...

2023/7/12

Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

Cancer discovery

Sriram Venneti

Abed Rahman Kawakibi

Sunjong Ji

Sebastian M Waszak

Stefan R Sweha

...

2023/11/1

See List of Professors in Carl Koschmann, MD University(University of Michigan)